90 research outputs found
Creep behaviors of ASTM A36 welded joints
This research work aimed to observe the creep behaviors of the ASTM A36 welded joints. The microstructure and hardness of the base zone (BZ), heat affected zone (HAZ), and weld fusion zone (WFZ) were measured. Afterward, the residual stresses on the welded plate were observed to determine any lead to fatigue failure. The hot tensile tests were then performed to investigate the welded specimens' creep behaviors at varied strain rates and temperatures. The power-law model was applied to describe the creep behaviors at each testing condition. Finally, the scanning electron microscopic (SEM) images of the tested specimens were observed to identify breakage causes. The creep results showed that the weakest locations were found in the base (A36) zones. The areas prone to ductile fracture was the base zones close to HAZ
Proteomic screen defines the hepatocyte nuclear factor 1Ī±-binding partners and identifies HMGB1 as a new cofactor of HNF1Ī±
Hepatocyte nuclear factor (HNF)-1Ī± is one of the liver-enriched transcription factors involved in many tissue-specific expressions of hepatic genes. The molecular mechanisms for determining HNF1Ī±-mediated transactivation have not been explained fully. To identify unknown proteins that interact with HNF1Ī±, we developed a co-IP-MS strategy to search HNF1Ī± interactions, and high mobility group protein-B1 (HMGB1), a chromosomal protein, was identified as a novel HNF1Ī±-interacting protein. In vitro glutathione S-transferase pull-down and in vivo co-immunoprecipitation studies confirmed an interaction between HMGB1 and HNF1Ī±. The proteināprotein interaction was mediated through the HMG box domains of HMGB1 and the homeodomain of HNF1Ī±. Furthermore, electrophoretic mobility shift assay and chromatin-immunoprecipitation assay demonstrated that HMGB1 was recruited to endogenous HNF1Ī±-responsive promoters and enhanced HNF1Ī± binding to its cognate DNA sequences. Moreover, luciferase reporter analyses showed that HMGB1 potentiated the transcriptional activities of HNF1Ī± in cultured cells, and downregulation of HMGB1 by RNA interference specifically affected the HNF1Ī±-dependent gene expression in HepG2 cell. Taken together, these findings raise the intriguing possibility that HMGB1 is a new cofactor of HNF1Ī± and participates in HNF1Ī±-mediated transcription regulation through proteināprotein interaction
Phosphodiesterase 3B Is Localized in Caveolae and Smooth ER in Mouse Hepatocytes and Is Important in the Regulation of Glucose and Lipid Metabolism
Cyclic nucleotide phosphodiesterases (PDEs) are important regulators of signal transduction processes mediated by cAMP and cGMP. One PDE family member, PDE3B, plays an important role in the regulation of a variety of metabolic processes such as lipolysis and insulin secretion. In this study, the cellular localization and the role of PDE3B in the regulation of triglyceride, cholesterol and glucose metabolism in hepatocytes were investigated. PDE3B was identified in caveolae, specific regions in the plasma membrane, and smooth endoplasmic reticulum. In caveolin-1 knock out mice, which lack caveolae, the amount of PDE3B protein and activity were reduced indicating a role of caveolin-1/caveolae in the stabilization of enzyme protein. Hepatocytes from PDE3B knock out mice displayed increased glucose, triglyceride and cholesterol levels, which was associated with increased expression of gluconeogenic and lipogenic genes/enzymes including, phosphoenolpyruvate carboxykinase, peroxisome proliferator-activated receptor Ī³, sterol regulatory element-binding protein 1c and hydroxyl-3-methylglutaryl coenzyme A reductase. In conclusion, hepatocyte PDE3B is localized in caveolae and smooth endoplasmic reticulum and plays important roles in the regulation of glucose, triglyceride and cholesterol metabolism. Dysregulation of PDE3B could have a role in the development of fatty liver, a condition highly relevant in the context of type 2 diabetes
GSI-I (Z-LLNle-CHO) inhibits Ī³-secretase and the proteosome to trigger cell death in precursor-B acute lymphoblastic leukemia
Gamma secretase inhibitors (GSIs) comprise a growing class of compounds that interfere with the membrane-bound Notch signaling protein and its downstream intra-nuclear transcriptional targets. As GSI-I (Z-LLNle-CHO) is also a derivative of a widely used proteosome inhibitor MG-132, we hypothesized that this compound might be active in precursor-B acute lymphoblastic leukemia (ALL) cell lines and patient samples. We found that GSI-I treatment of precursor-B ALL blasts induced apoptotic cell death within 18ā24āh. With confirmation using RNA and protein analyses, GSI-I blocked nuclear accumulation of cleaved Notch1 and Notch2, and inhibited Notch targets Hey2 and Myc. Microarray analyses of 207 children with high-risk precursor-B ALL demonstrate that Notch pathway expression is a common feature of these neoplasms. However, microarray studies also implicated additional transcriptional targets in GSI-I-dependent cell death, including genes in the unfolded protein response, nuclear factor-ĪŗB and p53 pathways. Z-LLNle-CHO blocks both Ī³-secretase and proteosome activity, inducing more robust cell death in precursor-B ALL cells than either proteosome-selective or Ī³-secretase-selective inhibitors alone. Using Z-LLNle-CHO in a nonobese diabetes/severe combined immunodeficiency (NOD/SCID) precursor-B ALL xenograft model, we found that GSI-I alone delayed or prevented engraftment of B-lymphoblasts in 50% of the animals comprising the experimental group, suggesting that this compound is worthy of additional testing
Investigation into Relationship Between Friction Behavior and Plastic Deformation Using a Newly Devised Rolling-Type Tribometer,"
- ā¦